-
What is Alzheimer’s disease, how common is it – and will new drug lecanemab help patients in the UK? | UK News
admin
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer’s disease. After an 18-month trial of 1,800 patients, lecanemab slowed patients’ mental decline by 27%. Although scientists are hailing a “new era” in treatment, strains on the NHS and the scale and complexity of the…
-
Alzheimers, cure, day, decline, dementia, doctors, drug, fuelling, hope, Lecanemab, memory, News, Science, slows, Tech
Lecanemab: New Alzheimer’s drug slows decline in memory – fuelling hope doctors will one day cure dementia | Science & Tech News
admin
Doctors have hailed a “new era” of medicine after a study showed for the first time that a drug can slow the debilitating symptoms of Alzheimer’s. Results from the clinical trial also revealed that the drug lecanemab cleared clumps of a protein called amyloid – thought to be a key cause of the most common…